EP0663827A4 - Tocolytic oxytocin receptor antagonists. - Google Patents

Tocolytic oxytocin receptor antagonists.

Info

Publication number: EP0663827A4
Authority: EP; European Patent Office
Prior art keywords: receptor antagonists; oxytocin receptor; tocolytic oxytocin; tocolytic; antagonists
Prior art date: 1992-10-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP93923134A

Other languages

German (de)

French (fr)

Other versions

EP0663827A1 (en

Inventor

Ben E Evans

Douglas W Hobbs

Joseph M Pawluczyk

Douglas J Pettibone

Kenneth E Rittle

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck and Co Inc

Original Assignee

Merck and Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-10-07

Filing date

1993-09-27

Publication date

1995-11-15

1993-09-27 Application filed by Merck and Co Inc filed Critical Merck and Co Inc

1995-07-26 Publication of EP0663827A1 publication Critical patent/EP0663827A1/en

1995-11-15 Publication of EP0663827A4 publication Critical patent/EP0663827A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

EP93923134A 1992-10-07 1993-09-27 Tocolytic oxytocin receptor antagonists. Withdrawn EP0663827A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US95793892A	1992-10-07	1992-10-07
US957938		1992-10-07
PCT/US1993/009152 WO1994007496A1 (en)	1992-10-07	1993-09-27	Tocolytic oxytocin receptor antagonists

Publications (2)

Publication Number	Publication Date
EP0663827A1 EP0663827A1 (en)	1995-07-26
EP0663827A4 true EP0663827A4 (en)	1995-11-15

Family

ID=25500372

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP93923134A Withdrawn EP0663827A4 (en)	1992-10-07	1993-09-27	Tocolytic oxytocin receptor antagonists.

Country Status (5)

Country	Link
EP (1)	EP0663827A4 (en)
JP (1)	JPH08502474A (en)
AU (1)	AU5292393A (en)
CA (1)	CA2143117A1 (en)
WO (1)	WO1994007496A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE216580T1 (en) *	1993-07-16	2002-05-15	Merck & Co Inc	BENZOXAZINONE AND BENZOPYRIMIDINONE PIPERIDINYL COMPOUNDS AS TOCOLYTIC OXYTOCIN RECEPTOR ANTAGONISTS
AU675730B2 (en) *	1993-07-16	1997-02-13	Merck & Co., Inc.	Substituted piperazinylcamphor derivatives as oxytocin antagonists
US5464788A (en) *	1994-03-24	1995-11-07	Merck & Co., Inc.	Tocolytic oxytocin receptor antagonists
US5707985A (en) *	1995-06-07	1998-01-13	Tanabe Seiyaku Co. Ltd.	Naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives as cell adhesion modulators
AU6747498A (en) *	1997-04-11	1998-11-11	Sumitomo Pharmaceuticals Company, Limited	Benzene derivatives
GB9819860D0 (en)	1998-09-12	1998-11-04	Zeneca Ltd	Chemical compounds
DK1307430T3 (en)	2000-07-05	2006-01-30	Ortho Mcneil Pharm Inc	Non-peptide-substituted spirobenzoazepines as vasopressin antagonists
CN101108825A (en)	2003-04-04	2008-01-23	麦克公司	Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
CA2529649C (en) *	2003-06-17	2012-01-31	Janssen Pharmaceutica N.V.	Substituted spirobenzazepines
DE102005000666B3 (en)	2005-01-04	2006-10-05	Sanofi-Aventis Deutschland Gmbh	Sulfonylpyrrolidines, process for their preparation and their use as pharmaceuticals
EP2076517A1 (en)	2006-09-22	2009-07-08	Janssen Pharmaceutica N.V.	Spiro benzazepines as vasopressin antagonists
CN101541806A (en)	2006-09-22	2009-09-23	詹森药业有限公司	Spiro benzazepines used as vasopressin antagonists
EP2102207B1 (en)	2006-12-07	2010-06-02	F.Hoffmann-La Roche Ag	Spiro-piperidine derivatives as via receptor antagonists
CN101563324A (en) *	2006-12-22	2009-10-21	弗·哈夫曼-拉罗切有限公司	Spiro-piperidine derivatives
JP2010513385A (en) *	2006-12-22	2010-04-30	エフ．ホフマン−ラロシュアーゲー	Spiro-piperidine derivatives
US20100022572A1 (en)	2008-07-18	2010-01-28	Kowa Company, Ltd.	Novel spiro compound and medicine comprising the same
KR101756495B1 (en) *	2010-03-11	2017-07-10	다이닛본 스미토모 세이야꾸 가부시끼가이샤	N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
US11717499B2 (en) *	2011-06-28	2023-08-08	Sandra Eve Reznik	Administration of N,N-dimethylacetamide for the treatment of preterm birth
JP5715605B2 (en) *	2011-09-14	2015-05-07	大日本住友製薬株式会社	Pharmaceutical comprising N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
WO2014024993A1 (en) *	2012-08-09	2014-02-13	国立大学法人京都大学	Piperazine derivative and use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0444945A2 (en) *	1990-03-02	1991-09-04	Merck & Co. Inc.	Use of spirocyclic compounds as oxytocin antagonists
EP0486280A2 (en) *	1990-11-13	1992-05-20	Merck & Co. Inc.	Piperidinylcamphorsulfonyl oxytocin antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8917069D0 (en) *	1989-07-26	1989-09-13	Merck Sharp & Dohme	Therapeutic agents
US5091387A (en) *	1990-03-02	1992-02-25	Merck & Co., Inc.	Spirocyclic oxytocin antagonists
EP0445974A3 (en) *	1990-03-05	1992-04-29	Merck Sharp & Dohme Ltd.	Spirocyclic antipsychotic agents

1993
- 1993-09-27 CA CA002143117A patent/CA2143117A1/en not_active Abandoned
- 1993-09-27 AU AU52923/93A patent/AU5292393A/en not_active Abandoned
- 1993-09-27 WO PCT/US1993/009152 patent/WO1994007496A1/en not_active Application Discontinuation
- 1993-09-27 EP EP93923134A patent/EP0663827A4/en not_active Withdrawn
- 1993-09-27 JP JP6509222A patent/JPH08502474A/en active Pending

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0444945A2 (en) *	1990-03-02	1991-09-04	Merck & Co. Inc.	Use of spirocyclic compounds as oxytocin antagonists
EP0486280A2 (en) *	1990-11-13	1992-05-20	Merck & Co. Inc.	Piperidinylcamphorsulfonyl oxytocin antagonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9407496A1 *

Also Published As

Publication number	Publication date
AU5292393A (en)	1994-04-26
CA2143117A1 (en)	1994-04-14
EP0663827A1 (en)	1995-07-26
JPH08502474A (en)	1996-03-19
WO1994007496A1 (en)	1994-04-14

Legal Events

Date	Code	Title	Description
1995-06-09	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1995-07-26	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
1995-08-16	17P	Request for examination filed	Effective date: 19950508
1995-11-15	A4	Supplementary search report drawn up and despatched	Effective date: 19951002
1995-11-15	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
1999-08-25	17Q	First examination report despatched	Effective date: 19990708
2000-03-24	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2000-05-10	18D	Application deemed to be withdrawn	Effective date: 19991119

Publication	Publication Date	Title
EP0751773A4 (en)	1997-07-16	Tocolytic oxytocin receptor antagonists
EP0676959A4 (en)	1996-01-03	Endothelin receptor antagonists.
EP0667773A4 (en)	1996-09-25	Fibrinogen receptor antagonists.
EP0668075A3 (en)	1996-10-16	Non-peptide tachykinin receptor antagonists.
EP0663827A4 (en)	1995-11-15	Tocolytic oxytocin receptor antagonists.
EP0486280A3 (en)	1992-12-09	Piperidinylcamphorsulfonyl oxytocin antagonists
EP0612244A4 (en)	1995-05-17	Endothelin receptor antagonists.
ZA948541B (en)	1995-05-02	Endothelin receptor antagonists
HU9603082D0 (en)	1997-01-28	Neurokinine (tachykinine) antagonists
EP0763035A4 (en)	1997-10-01	Endothelin receptor antagonists
HU9603525D0 (en)	1997-02-28	Vironectin receptor antagonists
PH31071A (en)	1998-02-05	Substituted pyrridopyrimidines useful antgiotensinII antagonists.
EP0729472A4 (en)	1997-03-19	Piperidinylcamphorsulfonyl oxytocin antagonists
IL109443A0 (en)	1994-07-31	Endothelin receptor antagonists
ZA938014B (en)	1994-07-11	Bradykinin antagonists.
HU9601176D0 (en)	1996-06-28	Adhesion-receptor antagonists
EP0684823A4 (en)	1997-07-09	Fibrinogen receptor antagonists.
EP0766684A4 (en)	1997-07-16	Endothelin receptor antagonists
EP0805681A4 (en)	1998-05-06	Tocolytic oxytocin receptor antagonists
EP0666851A4 (en)	1995-08-30	Substituted phthalazinones as nerotensin antagonists.
SG50426A1 (en)	1998-07-20	Lhrh antagonists
HU9503191D0 (en)	1996-01-29	Adhesion-receptor antagonists
GB9813103D0 (en)	1998-08-19	Tocolytic oxytocin receptor antagonists
HU9403017D0 (en)	1994-12-28	New endothelin antagonists ii.
EP0768878A4 (en)	1999-02-17	Endothelin receptor antagonists